Average Co-Inventor Count = 10.66
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Bristol-myers Squibb Compnay (32 from 3,681 patents)
2. Syngene International Limited (2 from 7 patents)
3. Merck Patent Gmbh (1 from 2,937 patents)
31 patents:
1. 12473304 - Heterocyclic PAD4 inhibitors
2. 12286428 - Tricyclic heteroaryl compounds useful as IRAK4 inhibitors
3. 12059420 - Inhibitors of indoleamine 2,3-dioxygenase and methods of their use
4. RE49893 - [1,2,4]triazolo[1,5-a]pyridinyl substituted indole compounds
5. RE49880 - [1,2,4]triazolo[1,5-a]pyridinyl substituted indole compounds
6. 11739098 - Substituted indole compounds
7. 11672780 - [1,2,4]triazolo[1,5-a]pyridinyl substituted indole compounds
8. 10959986 - Inhibitors of indoleamine 2,3-dioxygenase and methods of their use
9. 10912766 - [1,2,4]triazolo[1,5-A]pyridinyl substituted indole compounds
10. 10730863 - Bridged bicyclic compounds as farnesoid X receptor modulators
11. 10660877 - Pyridyl substituted indole compounds
12. 10618903 - Heteroaryl substituted aminopyridine compounds
13. 10544120 - Biaryl kinase inhibitors
14. 10544133 - Heteroaryl substituted pyridyl compounds useful as kinase modulators
15. 10399932 - Inhibitors of indoleamine-2,3-dioxygenase for the treatment of cancer